본문 바로가기

Development of a validated liquid chromato-graphy–tandem mass spectrometry assay for the quantification of simvastatin acid, the active metabolite of simvastatin, in human plasma

문서 유형
연구출판물 · 학술지 논문
등재
KCIScopus
저널 순위
Scopus Q4
저널
Translational and Clinical Pharmacology24(1) · pp.22 · 2016
피인용
KCI 0
ISSN
2289-0882

저자

  1. 박현정제1저자서울아산병원
  2. 황애경서울아산병원
  3. 김아름서울아산병원
  4. 김수현서울아산병원
  5. 김은화서울아산병원
  6. 조상헌인하대학교
  7. 김종률인제대학교
  8. 최상민부산대학교병원
  9. 정진아인제대학교부속부산백병원
  10. 진석준울산대학교
  11. 배균섭울산대학교
  12. 임형석교신저자울산대학교

초록

Simvastatin is a lipid-lowering drug that is metabolized to its active metabolite simvastatin acid (SA). We developed and validated a sensitive liquid chromatography–tandem mass spectrometry (LC/MS/MS) method to quantitate SA in human plasma using a liquid–liquid extraction method with methanol. The protonated analytes generated in negative ion mode were monitored by mul-tiple reaction monitoring. Using 500-mL plasma aliquots, SA was quantified in the range of 0.1–100 ng/mL. Calibration was performed by internal standardization with lovastatin acid, and regression curves were generated using a weighting factor of 1/x². The linearity, precision, and accuracy of this assay for each compound were validated using quality control samples consisting of mixtures of SA (0.1, 0.5, 5, and 50 ng/mL) and plasma. The intra-batch accuracy was 95.3–107.8%, precision was –2.2% to –3.7%, and linearity (r²) was over 0.998 in the standard calibration range. The chromato¬graphic running time was 3.0 min. This method sensitively and reliably measured SA concentra¬tions in human plasma and was successfully used in clinical pharmacokinetic studies of simvastatin in healthy Korean adult male volunteers.

키워드

simvastatin acidplasmaLC/MS/MS

식별자

KCI
ART002091293